Aug 2026
Preclinical characterization of the efficacy and safety of histamine H3 receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment.
This research provides the first evaluation of LINS01022's analgesic efficacy and its favourable safety profile in neuropathic pain, and suggests that a novel H3R antagonist is a promising drug candidate and a valuable pharmacological tool for further investigation.
Magdalena Maciuszek, M. Białoń, Mateusz Królewski et al.
· European Journal of Pharmaco... · 0 citations